Last reviewed · How we verify
Bone Marrow Suppression due to Folic Acid Antagonism
Approved treatments
- Wellcovorin · Pfizer Japan Inc
- Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis.
Clinical guidelines
- FDA label — any
Leucovorin calcium is indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdoses of folic acid antagonists. - FDA label — any
Leucovorin calcium is indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdoses of folic acid antagonists. - FDA label — any
Leucovorin calcium is indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdoses of folic acid antagonists. - FDA label — any
Leucovorin calcium is indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdoses of folic acid antagonists. - FDA label — any
Leucovorin calcium is indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdoses of folic acid antagonists.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bone Marrow Suppression due to Folic Acid Antagonism patent landscape — cliff calendar, originator estates, attackable patents
- Bone Marrow Suppression due to Folic Acid Antagonism treatment landscape brief
- Bone Marrow Suppression due to Folic Acid Antagonism treatment updates RSS
Frequently asked questions about Bone Marrow Suppression due to Folic Acid Antagonism
What drugs treat Bone Marrow Suppression due to Folic Acid Antagonism?
Tracked treatments include Wellcovorin, Fusilev.
What is the treatment for Bone Marrow Suppression due to Folic Acid Antagonism?
Standard treatment for Bone Marrow Suppression due to Folic Acid Antagonism includes Wellcovorin, Fusilev. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Bone Marrow Suppression due to Folic Acid Antagonism?
FDA label publishes guidelines for Bone Marrow Suppression due to Folic Acid Antagonism. 5 guideline references tracked.
Related
- Treatment landscape: Bone Marrow Suppression due to Folic Acid Antagonism patent cliff · Bone Marrow Suppression due to Folic Acid Antagonism CI report
- Treatment: Wellcovorin · Pfizer Japan Inc
- Treatment: Fusilev · Spectrum Pharms
- Treatment: Fusilev · Acrotech Biopharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing